Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...

Key Milestone Signals Readiness for European Market Entry and Commitment to Quality ExaStim® ExaStim® Stimulation System Los ...

Elixir trails J&J’s Shockwave but has outpaced Bolt Medical to the European market with its mechanical IVL system.

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

Elixir Medical announced today that it received CE mark for its LithiX hertz contact (HC) intravascular lithotripsy (IVL) ...

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

"Prof. Valmed" was the first company to receive approval from the European Union for its co-pilot of the same name.

Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced today the appointment of Dr. James (Jim) Ulchaker, a ...

Revenue and Sales Performance: For the fiscal third quarter of 2025, Biomerica reported net sales of $1.10 million, a 10% increase from $1.00 million recorded in the same quarter of the previous year.

YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- ...

Financing will support clinical and regulatory development of DRYUM, novel and easy to use incisional negative pressure wound therapy system, with first clinical focus in orthopedic surgeryRegulatory ...

In November 2018 an Irish spinal surgeon travelled to Portugal for a conference featuring some of the world’s top scoliosis ...